Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IOM 510(k) Committee Publishes Recap Report As It Mulls Reforms

This article was originally published in The Gray Sheet

Executive Summary

The Institute of Medicine committee charged with reviewing the public health effectiveness of FDA's 510(k) review process published a report recapping its work to date, in a lead-up to formal reform recommendations.

You may also be interested in...



Hamburg: FDA Aims To Issue 510(k) Reform Plan By Year-End

FDA hopes to issue a list of planned 510(k) reforms by the end of the year, Commissioner Margaret Hamburg told more than 1,700 device industry stakeholders Oct. 20 at AdvaMed's annual conference in Washington, D.C.

Hamburg: FDA Aims To Issue 510(k) Reform Plan By Year-End

FDA hopes to issue a list of planned 510(k) reforms by the end of the year, Commissioner Margaret Hamburg told more than 1,700 device industry stakeholders Oct. 20 at AdvaMed's annual conference in Washington, D.C.

FDA Maps Out Potential 510(k) Reforms In Long-Awaited Report

FDA released its highly anticipated proposals for reforming the 510(k) program last week, and industry reps acknowledged that many of the individual recommendations could benefit companies

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel